References
- Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 1988;49:151–76.
- Adler CH, Zimmerman RA, Savino PJ, Bernardi B, Bosley TM, Sergott RC. Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol 1992;32:502–6.
- McLaughlin MR, Jannetta PJ, Clyde BL, Subach BR, Comey CH, Resnick DK. Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 1999;90:1–8.
- Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: the clinical usefulness of botulinum toxin A in treating neurologic disorders. Neurology 1990;40:1332–6.
- Flanders M, Chin D, Boghen D. Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993;33:316–9.
- Jost WH, Kohl A. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001;248:21–4.
- Park YC, Lim JK, Lee DK, Yi SD. Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 1993;8:334–40.
- Yoshimura DM, Aminoff MJ, Tami TA, Scott AB. Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992;15:1045–9.
- Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol 1991;26:133–8.
- Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety and immunogenicity. Mov Disord 2005;20:592–7.
- Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C. Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev 2005;1:CD004899.
- Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 2008;115:585–91.
- Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Eur J Neurol 2009;16:392–8.
- Mazlout H, Kamoun Gargouri H, Triki W, Kéfi S, Brour J, El Afrit MA, Chéour M, Kraiem A. Safety and efficacy of botulinum toxin in hemifacial spasm. J Fr Ophtalmol 2013;36(3):242–6.
- Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC Hemifacial spasm: results of treatment with low dose botulinum toxin injection. J Med Assoc Thai 2004;87(10):1205–11.
- Dressler D, Hallet M. Immunological aspects of botox, dysport and myobloc/neurobloc. Eur J Neurol 2006;13:11–15.
- Montserrat L, Benito M. Facial synkinesis and aberrant regeneration of facial nerve. Adv Neurol 1988;49:211–24.
- Møller AR, Jannetta PJ. Hemifacial spasm: results of electrophysiologic recording during microvascular decompression operations. Neurology 1985;35:969–74.
- Han H, Chen G, Zuo H. Microsurgical treatment for 55 patients with hemifacial spasm due to cerebellopontine angle tumors. Neurosurg Rev 2010;33:335–9.
- Nussbaum M. Hemifacial spasm associated with benign parotid tumor. Ann Otol Rhinol Laryngol 1977;86:73–4.